Loading...
Pemetrexed versus Gefitinib versus Erlotinib in Previously Treated Patients with Non-Small Cell Lung Cancer
BACKGROUND/AIMS: The efficacy and safety of pemetrexed, gefitinib, and erlotinib administration in previously treated patients with non-small cell lung cancer (NSCLC) were compared. METHODS: The study patients met the following criteria: histologically confirmed, previously treated advanced (stage I...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Korean Association of Internal Medicine
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2932943/ https://ncbi.nlm.nih.gov/pubmed/20830227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2010.25.3.294 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|